Miracle Mile Advisors LLC decreased its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 22.9% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 6,509 shares of the healthcare conglomerate’s stock after selling 1,930 shares during the quarter. Miracle Mile Advisors LLC’s holdings in UnitedHealth Group were worth $3,293,000 as of its most recent SEC filing.
Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in UNH. Kathleen S. Wright Associates Inc. bought a new stake in UnitedHealth Group during the third quarter worth about $27,000. Global Wealth Strategies & Associates boosted its holdings in shares of UnitedHealth Group by 152.4% in the 3rd quarter. Global Wealth Strategies & Associates now owns 53 shares of the healthcare conglomerate’s stock valued at $31,000 after buying an additional 32 shares during the last quarter. West Financial Advisors LLC acquired a new position in UnitedHealth Group during the third quarter worth $32,000. Quarry LP lifted its stake in UnitedHealth Group by 132.1% in the second quarter. Quarry LP now owns 65 shares of the healthcare conglomerate’s stock valued at $33,000 after acquiring an additional 37 shares during the last quarter. Finally, RPg Family Wealth Advisory LLC bought a new stake in shares of UnitedHealth Group in the 3rd quarter valued at about $37,000. 87.86% of the stock is currently owned by institutional investors and hedge funds.
Analyst Upgrades and Downgrades
A number of analysts have recently issued reports on the company. Royal Bank of Canada cut their price objective on UnitedHealth Group from $615.00 to $595.00 and set an “outperform” rating for the company in a research report on Wednesday, October 16th. Hsbc Global Res downgraded shares of UnitedHealth Group from a “strong-buy” rating to a “hold” rating in a report on Thursday, October 17th. HSBC raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $595.00 target price for the company in a report on Friday. Oppenheimer raised their price objective on shares of UnitedHealth Group from $610.00 to $640.00 and gave the stock an “outperform” rating in a research report on Friday, December 6th. Finally, TD Cowen increased their target price on UnitedHealth Group from $601.00 to $609.00 and gave the stock a “buy” rating in a research note on Friday, October 18th. Two investment analysts have rated the stock with a hold rating, nineteen have issued a buy rating and two have given a strong buy rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of “Buy” and an average target price of $626.79.
UnitedHealth Group Stock Performance
UnitedHealth Group stock opened at $541.28 on Tuesday. The business’s 50-day moving average price is $554.92 and its two-hundred day moving average price is $562.88. UnitedHealth Group Incorporated has a 12-month low of $436.38 and a 12-month high of $630.73. The company has a quick ratio of 0.91, a current ratio of 0.91 and a debt-to-equity ratio of 0.74. The stock has a market cap of $498.13 billion, a PE ratio of 35.26, a P/E/G ratio of 1.53 and a beta of 0.62.
UnitedHealth Group (NYSE:UNH – Get Free Report) last issued its earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share for the quarter, beating analysts’ consensus estimates of $7.00 by $0.15. UnitedHealth Group had a net margin of 3.63% and a return on equity of 26.37%. The firm had revenue of $100.82 billion for the quarter, compared to analyst estimates of $99.14 billion. During the same quarter last year, the business posted $6.56 earnings per share. The company’s quarterly revenue was up 9.2% on a year-over-year basis. As a group, analysts expect that UnitedHealth Group Incorporated will post 27.61 earnings per share for the current fiscal year.
UnitedHealth Group Announces Dividend
The company also recently declared a quarterly dividend, which was paid on Tuesday, December 17th. Stockholders of record on Monday, December 9th were paid a dividend of $2.10 per share. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.55%. The ex-dividend date was Monday, December 9th. UnitedHealth Group’s payout ratio is 54.72%.
UnitedHealth Group Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Further Reading
- Five stocks we like better than UnitedHealth Group
- Trading Halts Explained
- 2 Stocks to Gain From Trump Universal Tariffs on Critical Imports
- Investing In Automotive Stocks
- Rigetti Computing, Inc.: Buy, Sell, or Hold for 2025
- Energy and Oil Stocks Explained
- Delta Can Fly to New Highs in 2025; Here’s Why
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH – Free Report).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.